Patients with immune thrombocytopenia (ITP) who received a first-in-class investigational drug in addition to standard ...

Stage 1 ET is manageable with early intervention, lifestyle changes, and treatments like low-dose aspirin and cytoreductive therapy to reduce clotting risk. Meta: Stage 1 essential thrombocythemia is ...

A low platelet count is a condition in which the blood has fewer platelets than normal. Medically known as thrombocytopenia, ...

Prayagraj: The sale of antibiotics and drugs used to raise platelet count has seen a significant decline in Sangam City as dengue cases remain limited, said traders.Traders associated with the ...

Thrombocytopenia in chronic liver disease arises from a variety of factors related to liver disease etiology, progression, and treatment. It is common in patients with cirrhosis and is a distinctive ...

Chronic liver disease (CLD) and its advanced stage, cirrhosis, represent a significant global health burden, with portal hypertension (PH) being a primary driver of disease progression and ...

Background and objectives: Pathogen reduction technologies (PRTs) increase blood supply safety but may also increase platelet storage lesion, probably due to mitochondrial DNA damage. The purpose of ...

An expert discusses treatment strategies for immune thrombocytopenic purpura (ITP), emphasizing individualized decisions based on platelet count, bleeding symptoms, and comorbidities, with options ...

What Is Doptelet, and Why Does It Matter? Doptelet (avatrombopag) is a prescription medicine that helps the body make more platelets (cells that help stop bleeding). First approved in 2018 for adults, ...

Background: Since the mid-20th century, the widespread use of plastics has led to the buildup of harmful byproducts in the environment—most notably acrylamide (AA) and bisphenol A (BPA). These ...